George Tziras
Vorstandsvorsitzender bei SMALL PHARMA INC.
Vermögen: 447 982 $ am 30.04.2024
Aktive Positionen von George Tziras
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SMALL PHARMA INC. | Direktor/Vorstandsmitglied | 29.04.2021 | - |
| Vorstandsvorsitzender | 20.07.2022 | - | |
| Investor Relations Kontakt | - | - | |
| Corporate Officer/Principal | 29.04.2021 | 20.07.2022 | |
| CYBIN INC. | Direktor/Vorstandsmitglied | 23.10.2023 | - |
| Corporate Officer/Principal | 23.10.2023 | - | |
Small Pharma Ltd.
 Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2015 | - |
Karriereverlauf von George Tziras
Ehemalige bekannte Positionen von George Tziras
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SMALL PHARMA INC. | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - |
Ausbildung von George Tziras
| University of Oxford | Undergraduate Degree |
| The Paul H. Nitze School of Advanced International Studies | Graduate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Kanada | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SMALL PHARMA INC. | Retail Trade |
| CYBIN INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Unilock Capital Corp.
 Unilock Capital Corp. Financial ConglomeratesFinance Unilock Capital Corp. is a development stage company, which engages in the identification and evaluation of assets or businesses with a view to completing a qualifying transaction. It intends to become a capital pool industry. The company was founded on January 23, 2018 and is headquartered in Vancouver, Canada. | Finance |
- Börse
- Insiders
- George Tziras
- Erfahrung
